Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. (ELTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ELTX · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Elicio Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ELTX insider buying and selling by quarter
ELTX insider selling · ELTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ELTX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ELTX executive sell shares · ELTX board member insider trading · ELTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 2, 2026 | Connelly Robert CEO, President and Director | Award | 73,600 | — | Form 4 |
| Feb 2, 2026 | Shah Preetam See Remarks | Award | 24,000 | — | Form 4 |
| Feb 2, 2026 | DeMuth Peter Chief Scientific Officer | Award | 20,800 | — | Form 4 |
| Feb 2, 2026 | Haqq Christopher See Remarks | Award | 25,400 | — | Form 4 |
| Dec 9, 2025 | DeMuth Peter Chief Scientific Officer | Option | 362 | $2K | Form 4 |
| Mar 5, 2025 | Chudnovsky Yekaterina Director | Other | 3,500,573 | $20.34M⚡ | Form 4 |
| Dec 16, 2024 | DeMuth Peter Chief Scientific Officer | Option | 381 | $2K | Form 4 |
| Nov 26, 2024 | Venkatesan Jay Director | Other | 50,000 | $500 | Form 4 |
Connelly Robert
CEO, President and Director
Date
Feb 2
Shares
73,600
Price
—
Value
—
DeMuth Peter
Chief Scientific Officer
Date
Dec 9
Shares
362
Price
$4.41
Value
$2K
Chudnovsky Yekaterina
Director
Date
Mar 5
Shares
3,500,573
Price
$5.81
Value
$20.34M ⚡
DeMuth Peter
Chief Scientific Officer
Date
Dec 16
Shares
381
Price
$4.41
Value
$2K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ELTX insider trading
ELTX insider trades
Elicio Therapeutics, Inc. (ELTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DeMuth Peter (Chief Scientific Officer), Connelly Robert (CEO, President and Director), Shah Preetam (See Remarks). Over the past 12 months, 4 insiders have filed transactions with the SEC. ELTX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Elicio Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ELTX insider trading · 5 questionsThe insiders of Elicio Therapeutics, Inc. (ELTX) include executives and directors such as DeMuth Peter (Chief Scientific Officer), Connelly Robert (CEO, President and Director), Shah Preetam (See Remarks), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026